A multi-center, randomized, evaluator-blinded, prospective and comparative clinical trial to evaluate the efficacy and safety of the Lens Angle Supporter(LAS) for insertion of an intraocular lens in cataract surgery in cataract patients

osec0 个研究点目标入组 33 人开始时间: 待定最近更新: 2022年11月28日

试验速览

暂无简介。

•Selection Criteria
•1) Adult male and female patients aged 19 to 75 years
•2) Based on the cataract classification tool LOCS ?, among patients with cataract progression stage 2 or higher, patients requiring cataract surgery in both eyes
•3) Those who do not have clinically significant abnormalities in blood test before surgery
•4) Those who can participate during the clinical trial
•5) Those who voluntarily sign or seal the subject's consent for research participation

•1) Patients who have previously had surgery on the surgical site
•2) Patients with eye trauma or a history of trauma
•3) If the capsular bag or platoon is ruptured or there is a risk of rupture when inserting the product
•4) When an infectious disease is in progress in a part or tissue
•5) If there is a history of chronic or recurrent uveitis or similar
•6) Subjects with the following diseases are not eligible to participate in the clinical trial.
•- Congenital binocular cataract, medically incurable glaucoma patient, microophthalmos, recurrent inflammatory glomerulonephritis, anterior chamber collapse, proliferative diabetic retinopathy, endothelial dystrophy, acute eye disease
•7) If you are pregnant or lactating
•8) If it is related to the researcher involved in clinical evaluation
•9) In case the investigator judges that it is not suitable to participate in the clinical trial

发起方

osec